✦ LIBER ✦

Suicide gene therapy for pediatric tumors

✍ Scribed by Christian Beltinger; Wolfgang Uckert; Klaus-Michael Debatin

Publisher: Springer
Year: 2000
Tongue: English
Weight: 132 KB
Volume: 78
Category: Article
ISSN: 0946-2716
DOI: 10.1007/s001090000175

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecularly Targeted Therapy for Pediatr

Molecularly Targeted Therapy for Pediatric Brain Tumors

✍ Warren KE 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 233 KB

Current Progress in Suicide Gene Therapy

Current Progress in Suicide Gene Therapy for Cancer

✍ Kazuyuki Yazawa; William E. Fisher; F. Charles Brunicardi 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 95 KB

Suicide gene therapy usingE. coliβ-galac

Suicide gene therapy usingE. coliβ-galactosidase

✍ David Farquhar; Bih Pan; Mamoru Sakurai; Ajit Ghosh; Craig A. Mullen; Arly J. Ne 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 116 KB

Low-dose adriamycin remission maintenanc

Low-dose adriamycin remission maintenance therapy for pediatric solid tumors

✍ Eva V. Hvizdala; Diane M. Komp; John B. Arnold 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 1 views

A low-dose maintenance schedule of Adriamycin was evaluated in six children whose metastatic solid tumors regressed following toxic induction therapy with Adriamycin. Three of these children are now disease-free more than one year following discontinuation of therapy. Adriamycin can be given on a lo

High-dose rate intraoperative radiation

High-dose rate intraoperative radiation therapy for pediatric solid tumors

✍ Merchant, Thomas E.; Zelefsky, Michael J.; Sheldon, John M.; LaQuaglia, Michael 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views

Background. Sixteen pediatric patients with solid tumors received treatment on a protocol designed to test the feasibility and safety of high-dose rate intraoperative radiation therapy (IOHDR) via a remote afterloader. Patients and Methods. Patients with Ewing's sarcoma (n = 5), rhabdomyosarcoma (n

Enhancement of tumor killing using a com

Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy

✍ Rajagopal Ramesh; Anupama Munshi; Aizen J. Marrogi; Scott M. Freeman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 123 KB

Tumor cells genetically modified with the herpes simplex virus thymidine kinase (HSV-tk) gene in combination with ganciclovir (GCV) demonstrate a ''bystander effect''. Previous attempts to enhance the bystander tumor killing by combining cytokine genes with HSV-tk/GCV have met with varying results.